Combination Local Delivery Using a Stent
    1.
    发明申请
    Combination Local Delivery Using a Stent 审中-公开
    组合使用支架本地交付

    公开(公告)号:US20100092534A1

    公开(公告)日:2010-04-15

    申请号:US12249576

    申请日:2008-10-10

    摘要: Described herein are implantable medical devices useful in treating vascular conditions such as restenosis. In one embodiment, stents are described in which a combination of bioactive agents is described for local delivery in the vasculature. The combination of bioactive agents comprises at least one compound capable of inhibiting smooth muscle cell proliferation and at least one compound capable of mitigating MCP- and/or TF induction. For example, a compound capable of inhibiting smooth muscle cell proliferation is a mTOR inhibitor and a compound capable of mitigating MCP-1 and/or TF induction is a corticosteroid.

    摘要翻译: 本文描述了可用于治疗诸如再狭窄的血管病变的可植入医疗装置。 在一个实施方案中,描述了支架,其中描述了生物活性剂的组合用于脉管系统中的局部递送。 生物活性剂的组合包含至少一种能够抑制平滑肌细胞增殖的化合物和至少一种能够减轻MCP-和/或TF诱导的化合物。 例如,能够抑制平滑肌细胞增殖的化合物是mTOR抑制剂,能够缓解MCP-1和/或TF诱导的化合物是皮质类固醇。

    Medical devices to treat or inhibit restenosis
    2.
    发明申请
    Medical devices to treat or inhibit restenosis 审中-公开
    用于治疗或抑制再狭窄的医疗器械

    公开(公告)号:US20070142905A1

    公开(公告)日:2007-06-21

    申请号:US11567821

    申请日:2006-12-07

    IPC分类号: A61F2/02 A61F2/82

    摘要: Implantable medical devices having anti-restenotic coatings are disclosed. Specifically, implantable medical devices having coatings of certain NF-kappaB inhibitors, particularly certain dialkyl fumarates, are disclosed. Dimethyl fumarate is a particularly preferred dialkyl fumarate. The anti-restenotic medical devices include stents, catheters, micro-particles, probes and vascular grafts. Intravascular stents are preferred medical devices. The medical devices can be coated using any method known in the art including compounding the dialkyl fumarate with a biocompatible polymer prior to applying the coating. Moreover, medical devices composed entirely of biocompatible polymer-dialkyl fumarate blends are disclosed. Additionally, medical devices having a coating comprising at least one dialkyl fumarate in combination with at least one additional therapeutic agent are also disclosed. Furthermore, related methods of using and making the anti-restenotic implantable devices are also disclosed.

    摘要翻译: 公开了具有抗再狭窄涂层的可植入医疗装置。 具体地,公开了具有某些NF-κB抑制剂,特别是某些二烷基富马酸盐的包衣的可植入医疗器械。 富马酸二甲酯是特别优选的富马酸二烷基酯。 抗再狭窄医疗器械包括支架,导管,微粒,探针和血管移植物。 血管内支架是优选的医疗装置。 可以使用本领域已知的任何方法涂覆医疗装置,包括在施加涂层之前将富马酸二烷基酯与生物相容性聚合物混合。 此外,公开了完全由生物相容性聚合物 - 富马酸二烷基酯混合物组成的医疗装置。 此外,还公开了具有包含至少一种富马酸二烷基酯与至少一种另外的治疗剂组合的涂层的医疗装置。 此外,还公开了使用和制备抗再狭窄植入式装置的相关方法。

    Method and system for configuring an integrated circuit
    6.
    发明授权
    Method and system for configuring an integrated circuit 有权
    用于配置集成电路的方法和系统

    公开(公告)号:US07314174B1

    公开(公告)日:2008-01-01

    申请号:US10970964

    申请日:2004-10-22

    IPC分类号: G06K7/10 G06K9/36 G06K9/80

    CPC分类号: H03K19/177

    摘要: A system for programming configuration memory cells in an integrated circuit. The system includes: a set of data registers, wherein a member of the set has a temporary storage for a fixed number of configuration bits; and a plurality of rows, each row has a plurality of columns, wherein configuration memory cells in a selected column and in a selected row are programmed using the fixed number of configuration bits.

    摘要翻译: 一种用于在集成电路中编程配置存储单元的系统。 该系统包括:一组数据寄存器,其中该组的成员具有固定数量的配置位的临时存储; 和多行,每行具有多个列,其中使用固定数量的配置位对所选列和所选行中的配置存储单元进行编程。